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Progesterone is essential in the luteal phase whereas luteal
Ovarian stimulation has been extensively used in the majority oestradiol may play only a permissive role on the endometof assisted reproduction units in order to improve the success rium. However, a rapid decline in oestradiol concentrations rate by increasing the number of oocytes and thus the number around the mid-luteal period may compromise the endoof embryos to be replaced. The resulting supraphysiological metrial integrity leading to poor IVF outcomes. A retroconcentrations of oestradiol have significant implications to spective analysis of 763 women aged <40 years undergoing the outcomes of IVF-embryo transfer treatment. Significantly their first IVF cycle and having ≤3 embryos replaced was lower implantation and pregnancy rates were shown in cycles undertaken. In cycles receiving human chorionic gonadwith high serum oestradiol concentrations on the ovulatory otrophin (HCG) for luteal support, 25th, 50th and 75th human chorionic gonadotrophin (HCG) day (Forman et al., centiles of the ratio of day-of-HCG oestradiol to mid-1988; Simón et al., 1995; Ng et al., 2000) . luteal oestradiol (oestradiol ratio) were 1.8, 2.8 and 5.0 A recent report (Sharara and McClamrock, 1999) found that respectively. Hormonal parameters were not different the ratio of day-of-HCG oestradiol to mid-luteal oestradiol between pregnant and non-pregnant cycles. The outcomes was highly predictive of successful outcome in IVF-embryo were similar irrespective of the oestradiol ratio. Progestertransfer. The ongoing pregnancy rate and implantation rate one supplementation was used instead when the HCG were significantly impaired if the above ratio was Ͼ5. It oestradiol was >18 000 pmol/l or there were features of was postulated that the endometrial integrity might become ovarian hyperstimulation syndrome. Pregnancy rates of compromised when there was a dramatic decline in oestradiol these hyperstimulated cycles were 16.7 and 11.4% per cycle concentrations around the mid-luteal period as reflected by a respectively when oestradiol ratio was ≤5.0 and >5.0. This high ratio. difference did not reach statistical significance. Our results
There are very few studies in the literature to clarify the could not find an adverse outcome in cycles showing a importance of rapid decline of oestradiol around the mid-luteal rapid decline in oestradiol during the mid-luteal phase.
phase in IVF treatment, especially with regard to cycles with Key words: implantation rate/IVF/luteal phase/oestradiol/preghigh oestradiol concentrations on the day of ovulatory dose of nancy rate HCG. The purpose of this study was to examine the effects of the decline of serum oestradiol concentrations around the mid-luteal phase on pregnancy rate and implantation rate in Introduction an IVF-embryo transfer programme. The success of implantation depends upon a perfect dialogue between good quality embryos and a receptive endometrium.
Materials and methods The endometrium in the follicular phase undergoes a progress-A retrospective study of infertile patients attending the Assisted ive increase in thickness due to hyperplasia of both glandular Reproduction Unit at the Department of Obstetrics and Gynaecology, and stromal elements under the stimulation of rising serum
The University of Hong Kong, for conventional IVF or intracytooestradiol concentration as a result of follicular development. plasmic sperm injection (ICSI) treatment from early 1993 to In addition, oestradiol induces the synthesis of specific proteins December 1998 was undertaken. Ethical approval was not required and growth factors. Progesterone is essential in allowing for this retrospective analysis. The indications for conventional IVF implantation in the endometrium. Under the influence of (n ϭ 637) included tubal (n ϭ 268), male (n ϭ 99), endometriosis progesterone, the endometrium undergoes sequential events (n ϭ 90), unexplained (n ϭ 112) and mixed factors (n ϭ 68). ICSI (n ϭ 126) was performed for couples with severe semen abnormalities including maturation, secretory transformation of the glandular where Ͻ10 6 motile spermatozoa were recovered after sperm The details of the long protocol of ovarian stimulation regimen used HMG duration (days) 11.0 (9-19) 11.0 (8-19) NS at our centre had been previously published (Ng et al., 1997 (Ng et al., , 2000 . leading follicle reached 18 mm in diameter and there were at least three follicles Ͼ15 mm in diameter. The day of this HCG injection was designated as day 0. Transvaginal ultrasound-guided oocyte from the day of embryo transfer for 10 days. Serum oestradiol and NS ϭ not significant.
progesterone concentrations were measured 6 days after embryo transfer (day 10, mid-luteal phase). A urine pregnancy test was care. Mean implantation rate was the proportion of embryos transferred done 16 days after embryo transfer. If it was positive, ultrasound resulting in an intrauterine gestational sac. examination was performed 10-14 days later to confirm intrauterine As the data were not normally distributed, continuous data were pregnancy and to determine the number of gestation sacs present. expressed as median (2.5th-97.5th centiles). Hormonal data were Oestradiol was measured using a commercially available radiolog-transformed to correct for skewness prior to statistical analysis immunoassay kit (Diagnostic Products Corporation, Los Angeles, (Lenton et al., 1982) . Cycles receiving HCG and progesterone CA, USA). The inter-and intra-assay variabilities on high concentrasupplementation were analysed separately. Data on the type of tion control (oestradiol: 1082 pg/ml) were 4.2 and 4.0% respectively. treatment (IVF/ICSI), the age of women, the duration/dosage of HMG Progesterone was measured using a commercially available radioused, the number of oocytes obtained/fertilized, the fertilization/ immunoassay kit (Chiron Diagnostics Corporation, MA, USA) and cleavage rates, the pregnancy/implantation rates and the pregnancy the inter-assay and intra-assay variabilities were 9.4 and 8.4%
outcomes were compared between pregnant and non-pregnant cycles. respectively.
Statistical comparisons were carried out by Mann-Whitney U-test, Student's t-test, χ 2 -test and Kruskal-Wallis test, where appropriate.
Statistical analysis
Correlation was assessed by the Pearson method. Two-tailed P Ͻ 0.05 Fertilization rate was defined as the proportion of oocytes resulting was taken as significant. in two pronuclei formation and only metaphase II oocytes were counted in ICSI cycles. Only clinical pregnancies were considered in this study. A clinical pregnancy is defined by the presence of one or In all, 763 cycles were included in the analysis: 637 conventhe demonstration of gestational product in the uterine evacuate. Ontional IVF cycles and 126 ICSI cycles. Women were of median going pregnancies were those pregnancies beyond 10-12 weeks of gestation, at which stage the patients were referred out for antenatal age 34.0 years (2.5th-97.5th centiles: 28-37 years). The serum The number of oocytes fertilized and the number of embryos
Oestradiol ratio (day 0/day 10) 7.2 Ϯ 2.0 4.6 Ϯ 2.4 NS cleaved/replaced/frozen were significantly higher in pregnant cycles than non-pregnant cycles (Table I ). There were no
Values are given in geometric mean Ϯ SEM. Data were log-transformed prior to t-test.
differences in the type of treatment, the age of women, HMG Day 0 ϭ the day of ovulatory dose of human chorionic gonadotrophin.
dosage/duration, number of oocytes obtained, fertilization rate NS ϭ not significant.
and cleavage rate between pregnant and non-pregnant cycles. Hormonal parameters were similar in pregnant and nonpregnant cycles on day 0 and day 10 (Table II) . The 25th, 50th and 75th centiles of the ratio of day-of-HCG day 10) in these cycles were 3.5, 6.3 and 11.4 respectively. oestradiol to mid-luteal oestradiol, i.e. oestradiol ratio (day 0/ The outcomes were categorized into four groups according to day 10) were 1.8, 2.8 and 5.0 respectively. The outcomes were the quartiles of the above oestradiol ratio: Group A Ͻ3.5; categorized into four groups according to the quartiles of the Group B 3.5-6.29; Group C 6.3-11.4 and Group D Ͼ11.4. above oestradiol ratio: group A Ͻ1.8; group B 1.8-2.79; group Pregnancy rate, implantation rate, multiple pregnancy rate, and C 2.8-5.0; and group D Ͼ5.0. Pregnancy rate, implantation outcome of pregnancy were not significantly different among rate, multiple pregnancy rate and outcome of pregnancy were these four groups (Table V) . Difference in pregnancy and not significantly different among these four groups (Table III) .
implantation rates did not reach statistical significance when The oestradiol ratio (day 0/day 10) was significantly correlated the oestradiol ratio (day 0/day 10) was categorized into ഛ5.0 with the total number of eggs obtained (r ϭ -0.093, P ϭ 0.015) and Ͼ5.0 (Figure 1 ). The oestradiol ratio (day 0/day 10) was but not correlated with day-of-HCG oestradiol concentrations, not correlated with the total number of eggs obtained and dayafter log-transformation of the data.
of-HCG oestradiol concentrations, after log-transformation of the data.
Progesterone as luteal support
No differences were observed in all demographic and ovarian HCG versus progesterone as luteal support response parameters when pregnant cycles were compared to Compared with cycles receiving HCG supplementation: oestranon-pregnant cycles (data not shown). A similar number of diol on day 0, progesterone on day 10, oestradiol/progesterone embryos were replaced in pregnant and non-pregnant cycles.
on day 10 and oestradiol ratio (day 0/day 10) were significantly The hormonal profiles were also not different between pregnant higher in cycles receiving progesterone supplementation and non-pregnant cycles on day 0 and day 10 (Table IV) .
The 25th, 50th and 75th centiles of oestradiol ratio (day 0/ (Table VI) . (1993) suggested that the enhanced ovarian steroid secretion NS ϭ not significant.
in pregnant cycles could be due to a gonadotrophic stimulus such as HCG from the preimplantation embryo. In contrast to fertile subjects, mid-luteal oestradiol and progesterone concentrations during spontaneous cycles were similar between pregnant and non-pregnant cycles of infertile patients (Laufer et al., 1982) . The explanation for this difference between fertile and infertile women was still unknown. There is little recent information in humans with regard to the importance and necessity of luteal oestradiol during stimulated cycles in patients undergoing IVF-embryo transfer. Luteal phase serum oestradiol and progesterone concentrations were not related to the outcome of IVF treatment (Muasher et al., 1984; Mettler and Michelmann, 1987; Nylund et al., 1990) . On the other hand, Gidley-Baird et al. (1986) and Hutchinson-Williams et al. (1989) found significantly higher oestradiol concentrations during the mid-luteal period in pregnant than non-pregnant cycles. Different luteal supports including no support, HCG and progesterone were employed and this may explain the different results observed in these studies. Pituitary down-regulation was also not used in these studies. In this study, hormonal parameters were not significrates of cycles with oestradiol ratio ഛ6.3 and Ͼ6.3 in patients receiving progesterone supplementation.
antly different on day 0 and day 10 between pregnant and non-pregnant groups in cycles receiving HCG and progesterone Discussion as luteal support. Sharara and McClamrock (1999) recently found an adverse The role of oestradiol in the luteal phase seems to differ from outcome in 106 IVF-embryo transfer cycles using progesterone species to species. In rodents, oestradiol appears essential for supplementation when the ratio of day-of-HCG oestradiol to implantation. Blastocysts of rats and mice could implant only after the rise of luteal oestradiol around day 4 of gestation and mid-luteal oestradiol was Ͼ5. Impaired endometrial receptivity was suggested to be caused by a rapid decline in oestradiol examining the role of oestradiol and the decline of oestradiol concentrations in the luteal phase, i.e. a high oestradiol ratio.
concentrations during the mid-luteal phase on implantation In our programme, HCG was usually given on the day of rate and pregnancy rates of these hyperstimulated cycles. embryo transfer and 6 days after embryo transfer for the luteal In our programme, patients whose oestradiol concentrations support in cycles with oestradiol on the ovulatory HCG day on the day of HCG injection were Ͼ18 000 pmol/l or had Ͻ18 000 pmol/l. Our data showed that the number of embryos features suggestive of OHSS would receive progesterone replaced in the pregnant cycles (median 3; 2.5th-97.5th supplementation only in order to reduce the risk of OHSS. centiles: 2-3) was significantly higher than the non-pregnant Hormonal parameters on day 0 and day 10 were again not group (median 3; 2.5th-97.5th centiles: 1-3). Our results, found to be significantly different between pregnant and nonhowever, could not confirm an adverse effect of high oestradiol pregnant cycles. The pregnancy rates were 16.7% and 11.4% ratio around the mid-luteal phase on the outcomes in cycles per cycle respectively when oestradiol ratio (day 0/day 10) receiving HCG supplementation because similar outcomes was ഛ5.0 and Ͼ5.0. There seems to be a trend of a higher were observed in cycles with different oestradiol ratios.
pregnancy rate in those cycles with lower oestradiol ratio (day The results of our study were different from those of Sharara 0/day 10) or less rapid decline of oestradiol concentrations in and McClamrock (1999) . Their patients received either long the mid-luteal phase. De Ziegler et al. (1992) and Younis et al. or flare-up protocol of GnRH analogue and flushing of follicles (1994) only examined the endometrial biopsies taken from was not performed after egg collection. Luteal phase was cycles with oestradiol concentrations Ͻ10 000 pmol/l. Moresupported by i.m. progesterone (50-100 mg per day) only and over, de Ziegler et al. (1992) showed that endometrial oestradiol and progesterone concentrations were measured on morphology in those women not taking oestradiol in the luteal day 8 after the ovulatory HCG injection. All our patients were phase had smaller subnuclear vacuoles and these vacuoles down-regulated by taking Buserelin nasal spray and each were present in Ͻ50% of glandular cells. It will be important follicle was flushed once after aspiration. Cycles supported to examine the endometrium from cycles with oestradiol with HCG and progesterone in the luteal phase were separately concentrations Ͼ20 000 pmol/l and to compare the differences analysed. We checked serum oestradiol and progesterone between cycles with low and high oestradiol ratios. Moreover, concentrations 10 days after the HCG injection. It remains morphometry rather than traditional dating should be used to uncertain whether the discrepancy of the results could be due examine the endometrium in these cycles in order to detect to the different protocols of two programmes.
subtle differences in the morphology (Li et al., 1988) . Menopausal or functionally agonadal women could achieve
The reasons for a higher oestradiol ratio in some of the donor oocyte pregnancies without support of oestradiol in the cycles indicating a more rapid decline in oestradiol concentraluteal phase (Kapetanakis and Pantos, 1990; Stassart et al., tions around the mid-luteal phase were unknown. Oestradiol 1995; Zegers-Hochschild and Altieri, 1995). The permissive ratio (day 0/day 10) was not correlated with oestradiol concenfunction of luteal oestradiol in humans was also suggested trations on the day of HCG in cycles receiving HCG or by the examination of endometrial development. Mid-luteal progesterone supplementation whereas it was negatively correlendometrial morphology of glandular and stromal elements ated with the total number of oocytes obtained in cycles was not significantly affected by the cessation of oestradiol receiving HCG supplementation. The routine supplementation treatment and the reduction of oestradiol concentration to with oestradiol in addition to intravaginal progesterone luteal hypogonadic levels in the luteal phase after an adequate support was, however, not shown to affect the pregnancy rates follicular priming (de Ziegler et al., 1992; Younis et al., of down-regulated IVF cycles in a prospective randomized 1994). Endometrial maturation assessed by oestrogen and study (Smitz et al., 1993) . progesterone receptors showed the typical distribution of the In conclusion, our results could not find an adverse outcome normal mid-luteal endometrium in those patients with and in the cycles showing a rapid decline in oestradiol concentrawithout oestradiol supplementation in the luteal phase tions during the luteal phase whether HCG or progesterone (de Ziegler et al., 1992) . Our data on cycles receiving HCG supplementation was given. The endometrium from these supplementation may add further support to a permissive rather hyperstimulated cycles should be examined by morphometry than obligatory role of luteal oestradiol during the perito detect any subtle difference when there is a rapid decline implantation period in humans (Ghosh and Sengupta, 1995) .
of oestradiol concentrations around the mid-luteal phase. The suggestion that luteal oestradiol is not essential for normal endometrial development has not been examined in the hyperstimulated cycles. We have recently shown an association References between serum oestradiol Ͼ20 000 pmol/l on the day of HCG Baird, D.D., Wilcox, A.J., Weinberg, C.R. et al. (1997) Preimplantation injection and impaired implantation and pregnancy rates in hormonal differences between the conception and non-conception menstrual fresh IVF-embryo transfer cycles (Ng et al., 2000) . Excess tions. To the best of our knowledge, this is the first study
